BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 18354065)

  • 1. Association of clinical symptoms and cardiometabolic dysregulations in patients with schizophrenia spectrum disorders.
    Zhao C; Habtewold TD; Naderi E; Liemburg EJ; ; Bruggeman R; Alizadeh BZ
    Eur Psychiatry; 2023 Dec; 67(1):e7. PubMed ID: 38088065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cognitive ability and metabolic physical health in first-episode psychosis.
    Whitson S; O'Donoghue B; Hester R; Baldwin L; Harrigan S; Francey S; Graham J; Nelson B; Ratheesh A; Alvarez-Jimenez M; Fornito A; Pantelis C; Yuen HP; Thompson A; Kerr M; Berk M; Wood SJ; McGorry P; Allott K
    Schizophr Res Cogn; 2021 Jun; 24():100194. PubMed ID: 33659191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Schizophrenia and the retina: Towards a 2020 perspective.
    Silverstein SM; Fradkin SI; Demmin DL
    Schizophr Res; 2020 May; 219():84-94. PubMed ID: 31708400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose disturbances, cognitive deficits and white matter abnormalities in first-episode drug-naive schizophrenia.
    Zhang X; Yang M; Du X; Liao W; Chen D; Fan F; Xiu M; Jia Q; Ning Y; Huang X; Wu F; Soares JC; Cao B; Wang L; Chen H
    Mol Psychiatry; 2020 Dec; 25(12):3220-3230. PubMed ID: 31409883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health status and mobility limitations are associated with residential and employment status in schizophrenia and bipolar disorder.
    Strassnig M; Cornacchio D; Harvey PD; Kotov R; Fochtmann L; Bromet EJ
    J Psychiatr Res; 2017 Nov; 94():180-185. PubMed ID: 28743064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aerobic Exercise Improves Cognitive Functioning in People With Schizophrenia: A Systematic Review and Meta-Analysis.
    Firth J; Stubbs B; Rosenbaum S; Vancampfort D; Malchow B; Schuch F; Elliott R; Nuechterlein KH; Yung AR
    Schizophr Bull; 2017 May; 43(3):546-556. PubMed ID: 27521348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Self-Efficacy and Hemoglobin A1C Among Adults With Serious Mental Illness and Type 2 Diabetes: The Roles of Cognitive Functioning and Psychiatric Symptom Severity.
    Wykes TL; Lee AA; McKibbin CL; Laurent SM
    Psychosom Med; 2016 Apr; 78(3):263-70. PubMed ID: 27111458
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical performance and disability in schizophrenia.
    Strassnig M; Signorile J; Gonzalez C; Harvey PD
    Schizophr Res Cogn; 2014 Jun; 1(2):112-121. PubMed ID: 25254158
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosis prevalence and physical, metabolic and cognitive co-morbidity: data from the second Australian national survey of psychosis.
    Morgan VA; McGrath JJ; Jablensky A; Badcock JC; Waterreus A; Bush R; Carr V; Castle D; Cohen M; Galletly C; Harvey C; Hocking B; McGorry P; Neil AL; Saw S; Shah S; Stain HJ; Mackinnon A
    Psychol Med; 2014 Jul; 44(10):2163-76. PubMed ID: 24365456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetes and cognitive deficits in chronic schizophrenia: a case-control study.
    Han M; Huang XF; Chen DC; Xiu M; Kosten TR; Zhang XY
    PLoS One; 2013; 8(6):e66299. PubMed ID: 23840437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes is associated with lower global cognitive function in schizophrenia.
    Takayanagi Y; Cascella NG; Sawa A; Eaton WW
    Schizophr Res; 2012 Dec; 142(1-3):183-7. PubMed ID: 23031192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective lifestyle interventions to improve type II diabetes self-management for those with schizophrenia or schizoaffective disorder: a systematic review.
    Cimo A; Stergiopoulos E; Cheng C; Bonato S; Dewa CS
    BMC Psychiatry; 2012 Mar; 12():24. PubMed ID: 22443212
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of adherence to hypoglycemic medications between Type 2 diabetes patients with and without serious mental illness.
    Kreyenbuhl J; Leith J; Medoff DR; Fang L; Dickerson FB; Brown CH; Goldberg RW; Potts W; Dixon LB
    Psychiatry Res; 2011 Jun; 188(1):109-14. PubMed ID: 21459458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does adherence to medications for type 2 diabetes differ between individuals with vs without schizophrenia?
    Kreyenbuhl J; Dixon LB; McCarthy JF; Soliman S; Ignacio RV; Valenstein M
    Schizophr Bull; 2010 Mar; 36(2):428-35. PubMed ID: 18718883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic hypotheses for generalized cognitive deficits in schizophrenia: a new take on an old problem.
    Dickinson D; Harvey PD
    Schizophr Bull; 2009 Mar; 35(2):403-14. PubMed ID: 18689868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of exacerbated cognitive deficits in schizophrenia patients with comorbid diabetes.
    Dickinson D; Gold JM; Dickerson FB; Medoff D; Dixon LB
    Psychosomatics; 2008; 49(2):123-31. PubMed ID: 18354065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Behavioural studies of spatial working memory dysfunction in schizophrenia: a quantitative literature review.
    Piskulic D; Olver JS; Norman TR; Maruff P
    Psychiatry Res; 2007 Mar; 150(2):111-21. PubMed ID: 17292970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schizophrenia with obsessive-compulsive disorder and obsessive-compulsive disorder with poor insight: a neuropsychological comparison.
    Tumkaya S; Karadag F; Oguzhanoglu NK; Tekkanat C; Varma G; Ozdel O; Ateşçi F
    Psychiatry Res; 2009 Jan; 165(1-2):38-46. PubMed ID: 18995914
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.